BK Polyomavirus Consensus
- PMID: 35856634
- DOI: 10.1093/cid/ciac594
BK Polyomavirus Consensus
Conflict of interest statement
Potential conflicts of interest. M. M. reports a research grant from Alberta Innovates unrelated to this work; consulting fees paid to author from CSL Behring and from Novartis; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events paid to author from CSL Behring; and an unpaid role with Banff Foundation for Allograft Pathology. H. H. H. reports honoraria as a consultant for Molecular Probes, Vera Therapeutics, and AiCuris and honoraria as a Biotest speaker, Roche advisory panel member, and Gilead speaker. N. K. reports honoraria paid to author from Biotest (speaker), Astellas, Novartis, MSD, Takeda, and ExeVir. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment in
-
Reply to Author.Clin Infect Dis. 2022 Nov 30;75(11):2047-2048. doi: 10.1093/cid/ciac678. Clin Infect Dis. 2022. PMID: 35993127 No abstract available.